• Abbott Rapid Dx North America LLC Respiratory Test Kit BinaxNOW® Infectious Disease Immunoassay Respiratory Syncytial Virus Test (RSV) Nasopharyngeal Swab / Nasal Wash Sample 22 Tests CLIA Waived - KT/1 - 430122-KT
1 1

Abbott Rapid Dx North America LLC Respiratory Test Kit BinaxNOW® Infectious Disease Immunoassay Respiratory Syncytial Virus Test (RSV) Nasopharyngeal Swab / Nasal Wash Sample 22 Tests CLIA Waived - Kit - 430122-KT

Abbott Rapid Dx North America LLC Respiratory Test Kit BinaxNOW® Infectious Disease Immunoassay Respiratory Syncytial Virus Test (RSV) Nasopharyngeal Swab / Nasal Wash Sample 22 Tests CLIA Waived - Kit - 430122-KT

SKU

430122-KT
$514.99
$514.99
OFF Sold out
Shipping calculated at checkout.

In stock

  • American Express
  • Diners Club
  • Discover
  • Mastercard
  • Shop Pay
  • Visa
View full details
Description

Abbott Rapid Dx North America LLC Respiratory Test Kit BinaxNOW® Infectious Disease Immunoassay Respiratory Syncytial Virus Test (RSV) Nasopharyngeal Swab / Nasal Wash Sample 22 Tests CLIA Waived

This Respiratory Test Kit from BinaxNOW® is ideal for clinics, laboratories and point-of-care testing. Sold as a kit.

MF Id# 430122
Brand BinaxNOW®
Manufacturer Abbott Rapid Dx North America LLC
Country of Origin United States
Application Respiratory Test Kit
CLIA Classification CLIA Waived
CLIA Classified CLIA Waived
Contents 1 (22) Test Cards, Transfer Pipettes, Positive Control Swab, Negative Control Swab, Elution Solution, NP Patient Swabs, Product Insert, Procedure Card
Number of Tests 22 Tests
Product Dating McKesson Acceptable Dating: we will ship >= 90 days
Purchase Program Type Standard Purchase
Reading Type Visual Read
Sample Type Nasopharyngeal Swab / Nasal Wash Sample
Specialty Immunoassay
Test Format Test Card Format
Test Method Lateral Flow Method
Test Name Respiratory Syncytial Virus Test (RSV)
Test Type Infectious Disease Immunoassay
Time to Results 15 Minute Results
UNSPSC Code 41116144

Features

  • Alere BinaxNOW® RSV Card is an in vitro rapid immunochromatographic assay used to detect respiratory syncytial virus (RSV) fusion protein antigen in nasal wash and nasopharyngeal (NP) swab specimens from symptomatic patients
  • This test is intended for in vitro diagnostic use to aid in the diagnosis of respiratory syncytial virus infections in neonatal and pediatric patients under the age of 5
  • Retrospective nasal wash Sensitivity: 89% Specificity: 100%
  • Prospective NP swab Sensitivity: 93% Specificity 93%